Early Rhythm Control for Device-Detected Fast Heart Episodes
Part of Heart & circulation clinical trials.
This trial tests whether starting treatment early to control your heart's rhythm can help people with a heart device who have short bursts of a fast heartbeat (called atrial high rate episodes) but haven't yet been diagnosed with atrial fibrillation on a standard EKG or Holter monitor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a heart device (like a pacemaker, ICD, or loop recorder) that can detect fast heart rhythms from the upper chambers.
- In the last 3 months, your device must have recorded fast heart episodes that added up to more than 21 hours.
- You must not have had a standard EKG or Holter monitor show atrial fibrillation (AFib) in the past year (though a very short episode under 30 seconds is okay).
- You should not be taking certain heart rhythm medications (called Class Ic or III antiarrhythmics) right now.
- You must have a life expectancy of more than one year and not be in hospice or unable to get a heart transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a target heart rate (below 80 beats per minute) is better than a more lenient one for people with persistent or permanent atrial fibrillation. It aims to find the best way to control your heart rate and improve your quality of life.
This trial uses a procedure called electrical cardioversion (a controlled shock to restore a normal heart rhythm) to see if treating atrial fibrillation or atrial flutter can improve symptoms in people with heart failure. The goal is to find out if fixing the irregular heartbeat helps you breathe better, have more energy, and feel better overall.
This study follows patients who have a heart rhythm device (pacemaker, defibrillator, or resynchronization device) and have experienced brief episodes of fast irregular heartbeats detected by the device. The study compares treatment approaches to understand which helps patients stay healthier and feel better.
This trial uses a home heart monitor (a chest patch with an ECG) to study how atrial fibrillation (an irregular heartbeat) changes over time and how this may help manage symptoms. You may be included if you have a documented, short-lasting type of atrial fibrillation and a moderate amount of AF seen on a 14-day heart recording.
This trial tests an early treatment approach for people who had a recent ischemic stroke (a stroke caused by a blocked blood vessel) and have an irregular heart rhythm called atrial fibrillation (AF). It aims to lower the chance of having another stroke by treating AF as early as possible after the stroke.
This study looks at whether a “rate control” or “rhythm control” approach works better for people with CRT devices who still have atrial fibrillation. It aims to improve heart failure symptoms and help the heart pace more effectively.
Hear when a new Diseases of the Circulatory System trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.